Polypharmacy in Psychiatry Practice, Volume II PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Polypharmacy in Psychiatry Practice, Volume II PDF full book. Access full book title Polypharmacy in Psychiatry Practice, Volume II by Michael S Ritsner. Download full books in PDF and EPUB format.
Author: Michael S Ritsner Publisher: Springer Science & Business Media ISBN: 9400757999 Category : Medical Languages : en Pages : 321
Book Description
Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.
Author: Michael S Ritsner Publisher: Springer Science & Business Media ISBN: 9400757999 Category : Medical Languages : en Pages : 321
Book Description
Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.
Author: Michael S Ritsner Publisher: Springer Science & Business Media ISBN: 9400758057 Category : Medical Languages : en Pages : 287
Book Description
Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume set is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.
Author: Michael S Ritsner Publisher: Springer ISBN: 9789400757981 Category : Medical Languages : en Pages : 0
Book Description
Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.
Author: S. Nassir Ghaemi Publisher: CRC Press ISBN: 020390902X Category : Medical Languages : en Pages : 363
Book Description
This practical reference examines the advantages and disadvantages of polypharmacy in psychiatry, and provides up-to-date clinical guidelines on the appropriate use of combinations of pharmacological therapy in major psychiatric disorders-including multidisciplinary approaches to treatment, such as social work and psychopharmacology, and an examina
Author: Ilo E. Leppik Publisher: Elsevier Science & Technology ISBN: 9780444824554 Category : Medical Languages : en Pages : 259
Book Description
Hardbound. Until this century, there was no scientific method for developing and testing agents for the treatment of epilepsy. Physicians would often, from analogy to other conditions, try remedies which appeared to affect systems thought to be important in the onset of seizures. The many developments and treatment concepts in epilepsy research in the last half-century have culminated in the short reign of popularity of monotherapy. Monotherapy is now being challenged by rational polypharmacy, based on the theory that two or more antiepileptic agents with different mechanisms of action may be more beneficial. This volume addresses areas in which monotherapy may be made more rational, and proposes that rational polypharmacy is the natural extension of rational monotherapy. Numerous issues are explored which need further delineation with a goal of a comprehensive antiepileptic drug management program to be developed for each patient.
Author: Swapnil Gupta Publisher: Oxford University Press, USA ISBN: 0190654813 Category : Medical Languages : en Pages : 265
Book Description
The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term "deprescribing" refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits. Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour. As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.
Author: Michael S. Ritsner Publisher: Springer Science & Business Media ISBN: 9401786100 Category : Medical Languages : en Pages : 328
Book Description
This is the first comprehensive two-volume collection on anhedonia, a disorder that played an important role in psychopathology theories at the beginning of the twentieth century. Anhedonia is a condition in which the capacity of pleasure is partially or completely lost, and it refers to both a personality trait, and a “state symptom” in various neuropsychiatric and physical disorders. It has a putative neural substrate, originating in the dopaminergic mesolimbic and mesocortical reward circuit. Over the past three decades cognitive psychology and behavioral neuroscience have expanded our understanding of anhedonia and other reward-related processes. The aim of this new two-volume collection on anhedonia is to highlight the contributions of eminent scientists in this field as well as to provide readers with comprehensive accounts of recent developments as perceived by the authors. This monograph is divided into five parts. Volume I contains parts one and two (Conceptual Issues and Neurobiological Advances) including 14 chapters that serve as an introduction and overview of conceptual issues. Volume II contains three parts (Anhedonia in Psychotic Disorders, Anhedonia in Mood and Personality Disorders, and Anhedonia in Neurological and Physical Disorders) including 15 chapters that provide an overview of the construct, measurement of anhedonia in schizophrenia spectrum disorders, hedonic capacity and related factors in schizophrenia and schizoaffective disorder, anhedonia as an indicator of genetic liability for schizophrenia, and as a trait marker for depression, the role of an anhedonia in trauma-related disorders, anorexia nervosa, stress-induced eating disorders, schizotypal traits and risk of suicide. This book will be of interest to a broad spectrum of readers including psychiatrists, psychologists, neurologists, neuroscientists, endocrinologists, pharmacologists, general practitioners, geriatricians, graduate students, and health care providers in the fields of mental health.
Author: Katherine D. Warburton Publisher: Cambridge University Press ISBN: 1107092191 Category : Medical Languages : en Pages : 357
Book Description
The association between violence and mental illness is well studied, yet remains highly controversial. Currently, there does appear to be a trend of increasing violence in hospital settings, including both civilly and forensically committed populations. In fact, physical aggression is the primary reason for admission to many hospitals. Given that violence is now often both a reason for admission and a barrier to discharge, there is a pressing need for violence to be re-conceptualized as a primary medical condition, not as the by-product of one. Furthermore, treatment settings need to be enhanced to address the new types of violence exhibited in inpatient environments and this modification needs to be geared toward balancing safety with treatment. This book focuses on violence from assessment, through underlying neurobiology, to treatment and other recommendations for practice. This will be of interest to forensic psychiatrists, general adult psychiatrists, psychiatric residents, psychologists, psychiatric social workers and rehabilitation therapists.
Author: Michael S. Ritsner Publisher: Springer ISBN: 9401785910 Category : Medical Languages : en Pages : 352
Book Description
This is the first comprehensive two-volume collection on anhedonia, a disorder that played an important role in psychopathology theories at the beginning of the twentieth century. Anhedonia is a condition in which the capacity of pleasure is partially or completely lost, and it refers to both a personality trait, and a “state symptom” in various neuropsychiatric and physical disorders. It has a putative neural substrate, originating in the dopaminergic mesolimbic and mesocortical reward circuit. Over the past three decades cognitive psychology and behavioral neuroscience have expanded our understanding of anhedonia and other reward-related processes. The aim of this new two-volume collection on anhedonia is to highlight the contributions of eminent scientists in this field as well as to provide readers with comprehensive accounts of recent developments as perceived by the authors. This monograph is divided into five parts. Volume I contains parts one and two (Conceptual Issues and Neurobiological Advances) including 14 chapters that serve as an introduction and overview of conceptual issues. Volume II contains three parts (Anhedonia in Psychotic Disorders, Anhedonia in Mood and Personality Disorders, and Anhedonia in Neurological and Physical Disorders) including 15 chapters that provide an overview of the construct, measurement of anhedonia in schizophrenia spectrum disorders, hedonic capacity and related factors in schizophrenia and schizoaffective disorder, anhedonia as an indicator of genetic liability for schizophrenia, and as a trait marker for depression, the role of an anhedonia in trauma-related disorders, anorexia nervosa, stress-induced eating disorders, schizotypal traits and risk of suicide. This book will be of interest to a broad spectrum of readers including psychiatrists, psychologists, neurologists, neuroscientists, endocrinologists, pharmacologists, general practitioners, geriatricians, graduate students, and health care providers in the fields of mental health.
Author: Michael S Ritsner
Author: Michael S Ritsner
Author: Michael S Ritsner
Author: Michael S Ritsner
Author: S. Nassir Ghaemi
Author: Michael S. Ritsner
Author: Ilo E. Leppik
Author: Swapnil Gupta
Author: Michael S. Ritsner
Author: Katherine D. Warburton
Author: Michael S. Ritsner